Surgery Partners operates ambulatory surgery centers with 52% revenue concentration from private insurance payors and a quality score below minimum thresholds, making it a structurally risky holding despite positive short-term momentum and an attractive forward valuation.
Thesis pillars
- Private Insurance Concentration Payor Risk→Stable
- Quality Below Minimum Threshold→Stable
- High Short Interest Elevated Put Call→Stable
- +1 more pillar — see the Why tab for full reasoning
Surgery Partners, Inc. (SGRY) Stock Analysis
Recovery setup
Healthcare · Medical Care Facilities
Sell if holding. Engine safety override at $16.89: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: High short interest: 22%; Below-average business quality.
Surgery Partners owns and operates 176 surgical facilities — 157 ambulatory surgery centers and 19 licensed surgical hospitals — across 30 U.S. states, generating approximately $3.2 billion in revenue in 2025. Facility fees from surgical procedures fund nearly all patient... Read more
Sell if holding. Engine safety override at $16.89: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: High short interest: 22%; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 73. Score 5.1/10, moderate confidence.
Passes 7/9 gates (positive momentum, clean insider activity, no SEC red flags, news events none recent, earnings proximity 32d clear, semi cycle peak clear, materials cycle peak clear). Fails on favorable risk/reward ratio. Suitability: aggressive.
Recent developments
updated 2026-07-05Recent Developments — Surgery Partners, Inc.
Latest news
- NEWS Surgery Partners Q1 2026 Earnings Call Transcript — benzinga May 5, 2026 neutral
- NEWS Surgery Partners Affirms FY2026 Sales Guidance of $3.350B-$3.450B vs $3.411B Est — benzinga May 5, 2026 positive
- NEWS Surgery Partners Q1 Adj. EPS $(0.03) Beats $(0.12) Estimate, Sales $810.900M Beat $797.892M Estimate — benzinga May 5, 2026 positive
- NEWS Earnings Scheduled For May 5, 2026 — benzinga May 5, 2026 neutral
Generated 2026-07-05T17:50:31Z.
Upcoming dated catalysts
Thesis
Key Metrics
Quality Signals
Options Flow
Concentration Risks(10-K Item 1A)
- MEDIUMCustomergovernment payors43%10-K Item 1A: 'We derived approximately 43%, 41% and 42% of our revenue from government payors, including Medicare and Medicaid programs in 2025, 2024 and 2023, respectively.'
- HIGHCustomerprivate insurance payors52%10-K Item 1A: 'Payments from private insurance payors...represented approximately 52%...of our patient service revenue in 2025'
Model-generated analysis — not investment advice. Not a registered investment advisor. Past performance does not guarantee future results.
Show full disclosure ▾Hide full disclosure ▴
About TrendMatrix. TrendMatrix is a publisher of general securities research and market commentary. We publish on a regular schedule. All content is the same for every subscriber in a tier — we do not provide personalized investment advice and we do not take into account any individual subscriber's financial situation, investment objectives, risk tolerance, tax situation, or holdings.
Not investment advice. TrendMatrix is not a registered investment adviser. Our content is for informational and educational purposes only. Consult your own licensed investment adviser, broker, or tax professional before making any investment decision.
Conflicts and positions. The TrendMatrix editorial team frequently holds personal long-term positions in securities discussed. We disclose positions held at the time of publication on each piece. We maintain a trading-window policy: we do not initiate or close positions in the same direction as a TrendMatrix publication within 24 hours before or 72 hours after publication.
No paid promotion. TrendMatrix does not accept payment from any issuer, broker, or third party in exchange for coverage of any security. Our sole compensation is subscription revenue.
No fiduciary duty. No fiduciary, advisory, or agency relationship is created between you and TrendMatrix by reading our content or subscribing to our service.
Performance. Past performance is not indicative of future results. Performance figures reflect the published model only and do not reflect any individual subscriber's actual results.
Rating Breakdown
3 floor-breakers
Technicals below the gate floor. Component breakdown shows what dragged the score down.static
Unprofitable operations — net margin -2.3%. Quality floor flags this regardless of sector context.static
Ranks in the bottom of its industry peers on the composite signal. Better names in the same sector exist.static
Price Targets
Position Sizing
Risk Alerts
Earnings
Verdict History
Frequently Asked Questions
Sell if holding. Engine safety override at $16.89: a dimension score below its floor triggers a hard block regardless of the otherwise-positive setup — overall score 5.1/10. Specifically: High short interest: 22%; Below-average business quality. Chart setup: Death cross but MACD improving, RSI 73. Prior stop was $16.02. Score 5.1/10, moderate confidence.
Take-profit target: $17.09 (-0.8% upside). Prior stop was $16.02. Stop-loss: $16.02.
Concentration risk — Customer: private insurance payors (52.0%); Target reached (-9.3% upside); Quality below floor (3.1 < 4.0).
Surgery Partners, Inc. trades at a P/E of N/A (forward 26.3). TrendMatrix value score: 6.7/10. Verdict: Sell.
18 analysts cover SGRY with a consensus score of 4.1/5. Average price target: $18.
What does Surgery Partners, Inc. do?Surgery Partners owns and operates 176 surgical facilities — 157 ambulatory surgery centers and 19 licensed surgical...
Surgery Partners owns and operates 176 surgical facilities — 157 ambulatory surgery centers and 19 licensed surgical hospitals — across 30 U.S. states, generating approximately $3.2 billion in revenue in 2025. Facility fees from surgical procedures fund nearly all patient service revenue, split 52.3% from private insurance and 42.8% from government payors (Medicare/Medicaid).